Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)

To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma

NCT02956889 ·Status: TERMINATED ·Phase: PHASE2

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

NCT05463757 ·Status: RECRUITING

Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)

NCT00699829 ·Status: UNKNOWN

Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

NCT05257486 ·Status: COMPLETED

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

NCT00185302 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France

NCT04550247 ·Status: ACTIVE_NOT_RECRUITING

L19IL2/TNF in Patients With Basal Cell Carcinoma

NCT07227870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

NCT02690948 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)

NCT02574260 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

NCT03875079 ·Status: COMPLETED ·Phase: PHASE1

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

NCT02036476 ·Status: TERMINATED ·Phase: PHASE2

Reflectance Confocal Microscopy to Diagnose BCC

NCT03509415 ·Status: COMPLETED

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

NCT05741073 ·Status: RECRUITING

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

NCT01676779 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

NCT00139360 ·Status: COMPLETED ·Phase: PHASE2

Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma

NCT01455363 ·Status: COMPLETED ·Phase: NA

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

NCT03504696 ·Status: COMPLETED

The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.

NCT04093401 ·Status: WITHDRAWN ·Phase: NA

Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance

NCT03666325 ·Status: UNKNOWN ·Phase: PHASE2

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

NCT03284424 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

NCT03565406 ·Status: TERMINATED ·Phase: PHASE1

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

NCT03024866 ·Status: COMPLETED

Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma

NCT03546166 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)

NCT04968106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

NCT00289016 ·Status: COMPLETED ·Phase: PHASE2